Reproducibility and reliability of automated volumetric measurement of single preovulatory follicles using SonoAVC

Size: px
Start display at page:

Download "Reproducibility and reliability of automated volumetric measurement of single preovulatory follicles using SonoAVC"

Transcription

1 Reproducibility and reliability of automated volumetric measurement of single preovulatory follicles using SonoAVC Samuel Salama, M.D., a Elisangela Arbo, M.D., a,b Frederic Lamazou, M.D., a Jean Marc Levailllant, M.D., a Rene Frydman, M.D., a and Renato Fanchin, M.D., Ph.D. a a AP-HP, Service de Gynecologie-Obstetrique et Medecine de la Reproduction, H^opital Antoine Beclere, Clamart, France; Univ Paris-Sud, Clamart, France; INSERM, Clamart, France; and b Programa de Pos-graduacxao em Ci^encias Medicas, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil Objective: To evaluate the reproducibility and the reliability of an innovative, computer-assisted approach for automatically measuring ovarian follicles. Design: Prospective, comparative study. Setting: Hospital Beclere, Clamart, France. Patient(s): Fifteen infertile women undergoing IVF-ET in monodominant follicle cycles. Intervention(s): Just before oocyte retrieval, follicles were three-dimensionally reconstructed from transvaginal ultrasonographic images. Volumes were determined both manually by visual outlining of inner follicle borders (VOCAL) and automatically using SonoAVC. Each procedure was repeated three times. Follicular fluid volume indicated the actual follicle volume. Main Outcome Measure(s): Reproducibility and concordance of results were assessed by the intraclass correlation coefficient (ICC) and the limits of agreement method, respectively. Result(s): At any time, VOCAL (3.68, ml; 3.73, ml; 3.89, ml; median, ranges, respectively) and SonoAVC (3.57, ml; 3.71, ml; 4.07, ml, respectively) volume measurements failed to be statistically different from the corresponding actual follicle volume (3.60, ml). Reproducibility (ICC, 95% confidence intervals) of repeated VOCAL (0.95, ) and SonoAVC (0.97, ) measurements as well as 95% limits of agreement between actual volumes and VOCAL ( 0.48 to þ0.80 ml) and SonoAVC ( 0.61 to þ0.99 ml) measurements were comparable. Conclusion(s): Automatic measurement of ovarian follicle volumes from three-dimensionally reconstructed ultrasound images (SonoAVC) is a rapid and simple technique, which reproducibility and reliability are comparable to the semimanual technique (VOCAL). It opens new perspectives for the accurate and objective assessment of ovarian function by ultrasound. (Fertil Steril Ò 2010;93: Ó2010 by American Society for Reproductive Medicine.) Key Words: SonoAVC, VOCAL, 3D ultrasound, follicle volume, in vitro fertilization, preovulatory follicle Received September 28, 2008; revised December 22, 2008; accepted December 29, 2008; published online April 1, S.S. has nothing to disclose. E.A. has nothing to disclose. F.L. has nothing to disclose. J.M.L. has nothing to disclose. R.Fr. has nothign to disclose. R.Fa. has nothing to disclose. The present article was selected for oral presentation at the 64th annual meeting of the American Society for Reproductive Medicine, San Francisco, CA, November 8 12, Reprint requests: Renato Fanchin, M.D., Ph.D., Department of Obstetrics and Gynecology and Reproductive Medicine, H^opital Antoine Beclere, 157, rue de la Porte de Trivaux, 92141, Clamart, France (FAX: ; renato.fanchin@abc.aphp.fr). The objective, noninvasive appraisal of ovarian follicular status at ultrasound scans constitutes an invaluable parameter in the study of ovarian function. In assisted reproductive technologies (ART), it is a key element for determining follicle maturation and readiness for triggering ovulation (1). When performed on a routine basis, such a procedure has long been restricted to two-dimensional (2D), manual determination of follicle diameters, as follicle volume assessment remained unreliable, complex, and time-consuming. Yet, because ovarian follicles often display intricate shapes that depart from the ideal sphere or ellipsoid, manual determination of diameters only offers a pale reflection of follicle volume (2), a phenomenon that potentially misguides medical decisions. During the last decade, multiple refinements of transvaginal ultrasound transducers and signal-treatment softwares, in particular the Virtual Organ Computer-aided Analysis (VO- CAL) technology, have greatly improved both accuracy and user-friendliness of three-dimensional (3D) reconstruction of ovarian ultrasonographic images, thereby allowing the volumetric study of ovarian follicles (3, 4). Indeed, a previous study has demonstrated that VOCAL-assisted assessment of follicle volume provides more reliable results compared with those obtained from geometric extrapolation of 2D diameters (5). However, to determine follicle volume, and because of the often irregular shape of this anatomic structure, VOCAL technology requires the outlining of inner follicle borders, a manual process that has to be repeated from 6 to 30 times (every 30,15,9,or6 rotational angles) and that is, therefore, time-consuming and operator-dependent. This methodologic contingency prevents its routine use during the monitoring of assisted reproductive treatments /10/$36.00 Fertility and Sterility â Vol. 93, No. 6, April doi: /j.fertnstert Copyright ª2010 American Society for Reproductive Medicine, Published by Elsevier Inc.

2 To overcome these limitations, we tested an innovative approach derived from topologic segmentation technology that is complementary to VOCAL but allows, in a user-friendly interface, the automatic recognition of follicle borders, 3D follicle reconstruction, and follicle volume assessment (Sonography-based Automated Volume Count, SonoAVC). For this, we elected to evaluate the reproducibility of repeated SonoAVC results and to compare it with that of manual diameter and semimanual volume (VOCAL) measurements. In addition, we evaluated the concordance between actual follicle volumes and SonoAVC, manual diameter (2D), and semimanual volume (VOCAL) measurements, respectively. To avoid possible confounding effects of multiple preovulatory follicles on the reliability of our results, we preferred to use the experimental model of monodominant follicle in vitro fertilization-embryo transfer (IVF-ET), in which only one follicle reaches the preovulatory stage. MATERIALS AND METHODS Subjects Fifteen infertile women, 26 to 41 years of age, were studied prospectively. All of them met the following inclusion criteria: [1] both ovaries present, deprived of morphologic abnormalities, and adequately visualized in transvaginal ultrasound scans; [2] menstrual cycle length range between 25 and 35 days; [3] no current or past diseases affecting ovaries or gonadotropin or sex steroid secretion, clearance, or excretion; [4] no clinical signs of hyperandrogenism; [5] body mass indexes (BMI) ranging between 18 and 27.5 kg/m 2. An informed consent was obtained from all women, and this investigation received the approval of our internal institutional review board. Cycle Monitoring Cycle monitoring of monodominant IVF-ET cycles has been exhaustively described elsewhere (6). In brief, from cycle day 8 onward, selection of the dominant follicle was detected by transvaginal ultrasound. When the mean diameter of the dominant follicle exceeded 12 mm, to prevent the risk of premature LH peak and to control further follicular maturation, women were administered subcutaneously 0.5 mg of a GnRH antagonist (cetrorelix acetate; Cetrotide 0.25 mg, Serono Pharmaceuticals, Boulogne, France) and 150 IU of hmg (Menopur, Ferring Pharmaceuticals, Gentilly, France) daily until the day of hcg (Gonadotrophine Chorionique Endo, Organon Pharmaceuticals, Saint-Denis, France) administration. The choice of starting hmg treatment once follicle dominance had been achieved aimed at preventing the rescue of additional subordinated follicles. Eventually, women received a 5,000-IU hcg injection intramuscularly when the dominant follicle diameter ranged between 16 mm and 22 mm. The single oocyte was picked up approximately 34 hours after hcg administration and ET was performed 2 days after oocyte pickup. According to the present study s design, each patient had only one oocyte retrieved and only one embryo obtained and transferred. Luteal phase was supported with micronized progesterone (Estima Ge, Effik Pharmaceuticals, Bievres, France; 600 mg/day) administered daily by vaginal route starting on the evening of ET. Ultrasonographic Measurement of the Preovulatory Follicle Volume In the present investigation, by design, only one preovulatory follicle was obtained and measured in each patient. Within the 30 minutes before oocyte retrieval (approximately 9:00 a.m.), the preovulatory follicle was characterized using a MHz transvaginal ultrasound probe (RIC5-9H, General Electric Medical Systems, Paris, France) equipped with a 146 rotating head that allowed data acquisition for further 3D reconstruction. All examinations were performed by the same operator (S.S.). As depicted in Figure 1, for each follicle, three different types of measurements were made. First, we measured manually the mean follicular diameter (manual diameter measurement). For this, the two orthogonal diameters (d1 and d2) were determined at the largest follicle plane using 2D ultrasound by placing calipers at the inner follicle borders. Mean follicle diameter corresponded to (d1 þ d2)/2 and results were expressed in millimeters (mm). Second, preovulatory follicle volume was determined manually using offline 3D-reconstruction by means of a virtual organ computer aided analysis (VOCAL) technology (General Electric Healthcare, Kretz, Austria). For this, the region of interest in the 3D volume, which corresponded to the inner follicle border, was manually and progressively (every 30 ) set (VOCAL measurement). Third, the same follicle volume was reassessed automatically, in the same 3D-reconstructed images, using Sonography-based Automated Volume Count (SonoAVC) technology (General Electric Healthcare, Kretz, Austria), an approach that is based on topologic segmentation approach and that allows the automatic evaluation of follicle volumes (SonoAVC measurement). In brief, the SonoAVC algorithm identifies hypoechoic structures and their approximate shape (ovarian follicles) in the selected 3D matrix. Then, after having recognized the center of each structure, it is able to progressively calculate the exact number of surrounding voxels toward the structure borders (growth function) and extrapolate its volume. Volumes were expressed in milliliters (ml) and diameters were expressed in millimeters (mm). To assess reproducibility of measurements, we repeated each procedure (manual diameter, VOCAL, and SonoAVC measurements) three times for each preovulatory follicle. Estimation of the Actual Preovulatory Follicle Volume In the present investigation, actual preovulatory follicle volume was extrapolated from follicular fluid (FF) volume. Under transvaginal ultrasound guidance, FF from the single preovulatory follicle was thoroughly aspirated using a 10- ml syringe connected to a 35-mm, 17-gauge needle then maintained at steady temperature conditions (37 C) until 2070 Salama et al. Automatic measurement of follicles Vol. 93, No. 6, April 2010

3 FIGURE 1 The three types of measurements performed on the same preovulatory follicle: follicle 2D diameters (A), semimanual (VOCAL, B), and automatic (SonoAVC, C) volume measurements. Statistics The measure of central tendency used was the mean and the measure of variability was the standard error. Medians and ranges were used when normality of data distribution could not be ascertained. To assess the within-technique reproducibility for the three consecutive measurements, we calculated the intraclass correlation coefficient (ICC) (7) and its 95% confidence intervals (CI) for each parameter (manual diameter, VOCAL, and SonoAVC). The ICC is the ratio of the between-subject variability over the total variability, the latter including between- and within-subject variability, and it ranges from 0 to The ICC values exceeding 0.80 usually indicate adequate reproducibility. To assess concordance (reliability) between the actual preovulatory follicle volume (FF volume) with VOCAL and SonoAVC volumes, we used the limits of agreement method as reported by Bland and Altman (8) and ICC (95% CI) calculation. RESULTS Population Characteristics Patients were aged 36 (26 41) years, their BMI was 21.5 ( ) kg/m 2, and their infertility was because of male factor (n ¼ 7), tubal factor (n ¼ 3), endometriosis (n ¼ 1), dysovulation (n ¼ 3), and unexplained (n ¼ 1). Reproducibility of Measurements Reproducibility of the three consecutive manual diameter, semimanual volume (VOCAL), and automatic volume (SonoAVC) measurements of the preovulatory follicle, calculated by ICC and correspondent 95% CI, is presented in Table 1. Median manual diameters (ranges) were 18.4 ( ) mm, 18.9 ( ) mm, 19.4 ( ) mm, respectively, whereas VOCAL values were 3.68 ( ) ml, 3.73 ( ) ml, and 3.89 ( ) ml and SonoAVC values were 3.57 ( ) ml, 3.71 ( ) ml, and 4.07 ( ) ml, respectively. As shown in Table 1, manual diameter measurements corresponded to a lower ICC value (<0.80, which indicates poor reproducibility) compared with those of semimanual and automatic volume measurements. In addition, both VOCAL and SonoAVC volume measurements displayed adequate and comparable reproducibility with ICC values at 0.95 and 0.97, respectively. the oocyte was found and isolated. The FF volume was estimated by adding the volume contained in the aspiration syringe to the residual volume contained in the needle (0.5 ml). Reliability of Measurements The assessment of reliability of semimanual (VOCAL) and automatic (SonoAVC) volume measurements compared the actual volume of the preovulatory follicle, estimated by the Bland and Altman plot, is illustrated in Figure 2. At any time, the three VOCAL and SonoAVC volume results were not statistically different from actual follicular volumes (3.60, ml). Bland-Altman plot analysis indicated that the 95% limits of agreement between actual volumes and VOCAL ( 0.48 to þ0.80 ml) and SonoAVC ( 0.61 to þ0.99 ml) results were comparable (Table 2). The reliability Fertility and Sterility â 2071

4 TABLE 1 Reproducibility of the three consecutive manual diameter, manual volume (VOCAL), and automatic volume (SonoAVC) measurements of the preovulatory follicle. ICC 95% CI Manual diameters Manual volumes (VOCAL) Automatic volumes (SonoAVC) Note: ICC ¼ intraclass correlation coefficient; CI ¼ confidence interval. of VOCAL and SonoAVC volume measurement compared with the actual volume of the preovulatory follicle, estimated by the ICC calculation, were 0.96 ( ) and 0.95 ( ) respectively. DISCUSSION For long and for practical reasons, ovarian follicle diameters determined at 2D ultrasound scans remained the reference method to assess follicle sizes and, therefore, to anticipate the degree of follicle readiness to ovulation triggering. Yet, the correlation between the results of such a widespread technique in ART and the actual size of the preovulatory follicle volume is relatively poor (2, 5, 9). Indeed, preovulatory follicles are volumetric structures whose shape often is deformed by surrounding structures, such as other growing follicles as a result of controlled ovarian hyperstimulation (COH), cysts, pelvic organs, and so forth. Together with equipment features and operator skillfulness, the complex shapes frequently assumed by preovulatory follicles greatly contribute to explain the insufficient reliability of diametric measurements. Unfortunately, the first attempts to circumvent these limitations by determining the whole volume of ovarian follicles remained insufficient. Indeed, whereas the mathematic extrapolation of follicular volume from its 2D diameters is considered inaccurate (10), the use of 3D reconstruction technologies that require the freehand outlining of inner follicle borders (VOCAL) (9) are time-consuming and impractical for routine use. The present investigation evaluated both the reproducibility and reliability of an innovative, computer-assisted approach for automatically measuring the volume of preovulatory ovarian follicles (SonoAVC). We elected to study patients undergoing IVF-ET performed in single preovulatory follicle cycles rather than in COH cycles to make it simpler and more reliable to compare the results of different types of follicle measurements and the volume of follicular fluid aspirates. Our results indicated that automatic volume measurements (SonoAVC) are at least as reproducible and reliable as semimanual measurements (VOCAL), and both approaches showed a better reproducibility than routine 2D diameter measurements. These results confirm and expands those from a preliminary experience of the use of SonoAVC in the measurement of stimulated follicles of IVF-ET candidates (11). Moreover, the possible influence of other ultrasound machines, having other signal treatment specificities, on the reliability and reproducibility of SonoAVC constitute and important issue and should be addressed in further studies. The accurate and simple appraisal of the preovulatory follicle dimension using SonoAVC is by no means without consequences on the daily practice of ART. First, the manual, exhaustive recording of individual follicle diameters as it is practiced currently in the presence of the patient in most of ART centers worldwide may be time-consuming and imprecise. The possibility of rapidly scanning both ovaries for without-the-patient 3D image reconstruction and SonoAVC measurement of follicle volumes may constitute a practical option to improve reliability and friendliness of routine ovarian measurements. Further, because of the standardization of measurement technique and volumes information (12) FIGURE 2 Reliability of semimanual (VOCAL) and automatic (SonoAVC) volume measurements related to the actual volume (follicular fluid volume) of the preovulatory follicle, represented in Bland and Altman plots Salama et al. Automatic measurement of follicles Vol. 93, No. 6, April 2010

5 TABLE 2 Reliability of manual (VOCAL) and automatic (SonoAVC) volume measurements versus the actual volume of the preovulatory follicle, estimated by ICC calculation. Manual volume (VOCAL) actual volume measurements Automatic volumes (SonoAVC) actual volume measurements ICC 95% CI Note: ICC ¼ intraclass correlation coefficient; CI ¼ confidence interval. offered by SonoAVC, we can contemplate the possibility that intra- and interoperator variability could be reduced by this new approach. This issue deserves further investigation. Second, these technologic refinements instigate a complete revision of criteria used for determining follicle readiness for ovulation triggering, even if the relationship between follicle size and ART outcome has been the matter of debate. Whereas some investigators have observed a relationship between preovulatory follicle diameters (10, 13) or volumes (14) and oocyte/embryo competence in IVF-ET, in an extensive study including 9,933 follicles aspirated for IVF-ET, Salha et al. (15) were unable to relate follicle volume with oocyte preparedness to fertilization and embryo potential to implantation, despite the fact that in their series embryo implantation rates tended to be reduced when follicle volumes were either %1.0 or >5 ml. Additional prospective studies aiming at associating follicle volume measured by SonoAVC with oocyte/embryo competence are needed to verify the possible positive consequences of this methodology on the results of ART. In conclusion, our present results indicate that automatic measurement of ovarian follicle volumes from three-dimensionally reconstructed ultrasound images (SonoAVC) is a rapid and simple technique, which reproducibility and reliability are comparable to the semimanual technique (VO- CAL). Indeed, by extrapolation, in hyperstimulated ovaries, the possibility offered by SonoAVC of not having to measure manually the diameters of each follicle is very attractive (11). It opens new perspectives for the accurate and objective assessment of ovarian function by ultrasound, in particular, by encouraging the widespread use of follicle volumes instead of diameters in the monitoring of preovulatory follicle preparedness to controlled ovulation. These promising results suggest that simplicity and accuracy of SonoAVC will hopefully prompt clinicians to shift from 2D to 3D measurements in their daily assessment of such volumetric, irregular structures as ovarian follicles. Finally, the usefulness of SonoAVC in other clinical indications in reproductive medicine as the identification and counting of small antral follicles (16, 17), in an effort to rendering this important clinical indicator of ovarian reserve more reliable and operator-independent than conventional manual methodology, deserves further investigation. REFERENCES 1. Queenan JT, O Brien GD, Bains LM, Simpson J, Collins WP, Campbell S. Ultrasound scanning of ovaries to detect ovulation in women. Fertil Steril 1980;34: Penzias AS, Emmi AM, Dubey AK, Layman LC, DeCherney AH, Reindollar RH. Ultrasound prediction of follicle volume: is the mean diameter reflective? Fertil Steril 1994;62: Merce LT, Bau S, Barco MJ, Troyano J, Gay R, Sotos F, Villa A. Assessment of the ovarian volume, number and volume of follicles and ovarian vascularity by three-dimensional ultrasonography and power Doppler angiography on the hcg day to predict the outcome in IVF/ICSI cycles. Hum Reprod 2006;21: Jayaprakasan K, Hilwah N, Kendall NR, Hopkisson JF, Campbell BK, Johnson IR, et al. Does 3D ultrasound offer any advantage in the pretreatment assessment of ovarian reserve and prediction of outcome after assisted reproduction treatment? Hum Reprod 2007;22: Kyei-Mensah A, Zaidi J, Pittrof R, Shaker A, Campbell S, Tan SL. Transvaginal three-dimensional ultrasound: accuracy of follicular volume measurements. Fertil Steril 1996;65: Fanchin R, Mendez Lozano DH, Frydman N, Gougeon A, di Clemente N, Frydman R, et al. Anti-Mullerian hormone concentrations in the follicular fluid of the preovulatory follicle are predictive of the implantation potential of the ensuing embryo obtained by in vitro fertilization. J Clin Endocrinol Metab 2007;92: Shrout PE, Fleiss JL. Intraclass correlations: use in assessing rater reliability. Psychol Bull 1979;86: Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986;1: Amer A, Hammadeh ME, Kolkailah M, Ghandour AA. Three-dimensional versus two-dimensional ultrasound measurement of follicular volume: are they comparable? Arch Gynecol Obstet 2003;268: Wittmaack FM, Kreger DO, Blasco L, Tureck RW, Mastroianni L Jr, Lessey BA. Effect of follicular size on oocyte retrieval, fertilization, cleavage, and embryo quality in in vitro fertilization cycles: a 6-year data collection. Fertil Steril 1994;62: Raine-Fenning N, Jayaprakasan K, Clewes J, Joergner I, Bonaki SD, Chamberlain S, et al. SonoAVC: a novel method of automatic volume calculation. Ultrasound Obstet Gynecol 2008;31: Raine-Fenning NJ, Campbell BK, Clewes JS, Johnson IR. The interobserver reliability of ovarian volume measurement is improved with three-dimensional ultrasound, but dependent upon technique. Ultrasound Med Biol 2003;29: Dubey AK, Wang HA, Duffy P, Penzias AS. The correlation between follicular measurements, oocyte morphology, and fertilization rates in an in vitro fertilization program. Fertil Steril 1995;64: Ectors FJ, Vanderzwalmen P, Van hoeck J, Nijs M, Verhaegen G, Delvigne A, et al. Relationship of human follicular diameter with oocyte fertilization and development after in-vitro fertilization or intracytoplasmatic sperm injection. Hum Reprod 1997;12: Salha O, Nugent D, Dada T, Kaufmann S, Levett S, Jenner L, et al. The relationship between follicular fluid aspirate and oocyte maturity in in-vitro fertilization cycles. Hum Reprod 1998;13: Reuss ML, Kline J, Santos R, Levin B, Timor-Tritsch I. Age and the ovarian follicle pool assessed with transvaginal ultrasonography. Am J Obstet Gynecol 1996;174: Jayaprakasan K, Campbell BK, Clewes JS, Johnson IR, Raine- Fenning NJ. Three-dimensional ultrasound improves the interobserver reliability of antral follicle counts and facilitates increased clinical work flow. Ultrasound Obstet Gynecol 2008;31: Fertility and Sterility â 2073

Prospective evaluation of automated follicle monitoring in 58 in vitro fertilization cycles: follicular volume as a new indicator of oocyte maturity

Prospective evaluation of automated follicle monitoring in 58 in vitro fertilization cycles: follicular volume as a new indicator of oocyte maturity Prospective evaluation of automated follicle monitoring in 58 in vitro fertilization cycles: follicular volume as a new indicator of oocyte maturity Adela Rodrıguez-Fuentes, M.D., a Jairo Hernandez, Ph.D.,

More information

SonoAVC WHITE PAPER. Introduction. gehealthcare.com

SonoAVC WHITE PAPER. Introduction. gehealthcare.com SonoAVC Adela Rodriguez-Fuentes, MD; Jairo Hernandez, PhD; Angela Palumbo, PhD Centro de Asistencia a la Reproducción Humana de Canarias (FIVAP) WHITE PAPER Introduction Imaging methods are constantly

More information

Abstract. Introduction. RBMOnline - Vol 18. No Reproductive BioMedicine Online; on web 26 March 2009

Abstract. Introduction. RBMOnline - Vol 18. No Reproductive BioMedicine Online;  on web 26 March 2009 RBMOnline - Vol 18. No 5. 2009 658-663 Reproductive BioMedicine Online; www.rbmonline.com/article/3762 on web 26 March 2009 Article Automated follicle tracking improves measurement reliability in patients

More information

Sonography-based Automated Volume Count (SonoAVC): an efficient and reproducible method of follicular assessment

Sonography-based Automated Volume Count (SonoAVC): an efficient and reproducible method of follicular assessment GE Healthcare Sonography-based Automated Volume Count (SonoAVC): an efficient and reproducible method of follicular assessment Todd D. Deutch, MD Clinical Reproductive Endocrinology and Infertility Fellow

More information

Quantitative analysis of antral follicle number and size: a comparison of two-dimensional and automated three-dimensional ultrasound techniques

Quantitative analysis of antral follicle number and size: a comparison of two-dimensional and automated three-dimensional ultrasound techniques Ultrasound Obstet Gynecol 2010; 35: 354 360 Published online in Wiley InterScience (www.interscience.wiley.com). DOI: 10.1002/uog.7505 Quantitative analysis of antral follicle number and size: a comparison

More information

P. A. Peres Fagundes 1,2, R. Chapon 1,2, P. R. Olsen 2, A. K. Schuster 2, M. M. C. Mattia 2,3 and J. S. Cunha-Filho 1,2,4*

P. A. Peres Fagundes 1,2, R. Chapon 1,2, P. R. Olsen 2, A. K. Schuster 2, M. M. C. Mattia 2,3 and J. S. Cunha-Filho 1,2,4* Peres Fagundes et al. Reproductive Biology and Endocrinology (2017) 15:96 DOI 10.1186/s12958-017-0314-x RESEARCH Evaluation of three-dimensional SonoAVC ultrasound for antral follicle count in infertile

More information

IVM in PCOS patients. Introduction (1) Introduction (2) Michael Grynberg René Frydman

IVM in PCOS patients. Introduction (1) Introduction (2) Michael Grynberg René Frydman IVM in PCOS patients Michael Grynberg René Frydman Department of Obstetrics and Gynecology A. Beclere Hospital, Clamart, France Maribor, Slovenia, 27-28 February 2009 Introduction (1) IVM could be a major

More information

Three-dimensional ultrasound improves the interobserver reliability of antral follicle counts and facilitates increased clinical work flow

Three-dimensional ultrasound improves the interobserver reliability of antral follicle counts and facilitates increased clinical work flow Ultrasound Obstet Gynecol 28; 31: 439 444 Published online 1 March 28 in Wiley InterScience (www.interscience.wiley.com). DOI: 1.12/uog.531 Three-dimensional ultrasound improves the interobserver reliability

More information

Oocyte maturity and preimplantation development in relation to follicle diameter in gonadotropin-releasing hormone agonist or antagonist treatments

Oocyte maturity and preimplantation development in relation to follicle diameter in gonadotropin-releasing hormone agonist or antagonist treatments IN VITRO FERTILIZATION Oocyte maturity and preimplantation development in relation to follicle diameter in gonadotropin-releasing hormone agonist or antagonist treatments Daniela Nogueira, Ph.D., a Shevach

More information

Utility of color Doppler indices of dominant follicular

Utility of color Doppler indices of dominant follicular Ultrasound Obstet Gynecol 2002; 20: 592 596 Utility of color Doppler indices of dominant follicular Blackwell Science, Ltd blood flow for prediction of clinical factors in in vitro fertilization-embryo

More information

Vanessa N. Weitzman, M.D., Lawrence Engmann, M.D., Andrea DiLuigi, M.D., Donald Maier, M.D., John Nulsen, M.D., and Claudio Benadiva, M.D.

Vanessa N. Weitzman, M.D., Lawrence Engmann, M.D., Andrea DiLuigi, M.D., Donald Maier, M.D., John Nulsen, M.D., and Claudio Benadiva, M.D. Comparison of luteal estradiol patch and gonadotropin-releasing hormone antagonist suppression protocol before gonadotropin stimulation versus microdose gonadotropin-releasing hormone agonist protocol

More information

Relation between the Number and Size of Follicles in Ovulation Induction and the Rate of Pregnancy

Relation between the Number and Size of Follicles in Ovulation Induction and the Rate of Pregnancy Relation between the Number and Size of Follicles in Ovulation Induction and the Rate of Pregnancy Aseel Mosa Jabber M.SC.G.O. The department of Obstetrics and Gynecology, Faculty of Medicine Thi-qar university

More information

The serum estradiol/oocyte ratio in patients with breast cancer undergoing ovarian stimulation with letrozole and gonadotropins

The serum estradiol/oocyte ratio in patients with breast cancer undergoing ovarian stimulation with letrozole and gonadotropins Original Article Obstet Gynecol Sci 2018;61(2):242-246 https://doi.org/10.5468/ogs.2018.61.2.242 pissn 2287-8572 eissn 2287-8580 The serum estradiol/oocyte ratio in patients with breast cancer undergoing

More information

The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION. 22 September 2010

The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION. 22 September 2010 The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION 22 September 2010 100 µg/0.5 ml, solution for injection B/1 prefilled syringe + 1 needle (CIP code: 374 590-1) 150

More information

A Tale of Three Hormones: hcg, Progesterone and AMH

A Tale of Three Hormones: hcg, Progesterone and AMH A Tale of Three Hormones: hcg, Progesterone and AMH Download the Ferring AR ipad/iphone app from the Apple Store: http://bit.ly/1okk74m Interpreting Follicular Phase Progesterone Ernesto Bosch IVI Valencia,

More information

Interpreting follicular Progesterone: Late follicular Progesterone to Estradiol ratio is not influenced by protocols or gonadotropins used

Interpreting follicular Progesterone: Late follicular Progesterone to Estradiol ratio is not influenced by protocols or gonadotropins used Interpreting follicular Progesterone: Late follicular Progesterone to Estradiol ratio is not influenced by protocols or gonadotropins used Ellenbogen A., M.D., Shalom-Paz E., M.D, Asalih N., M.D, Samara

More information

Ovarian Response to Gonadotrophin Stimulation in Patients with Previous Endometriotic Cystectomy

Ovarian Response to Gonadotrophin Stimulation in Patients with Previous Endometriotic Cystectomy Ovarian Response to Gonadotrophin Stimulation in Patients with Previous Endometriotic Cystectomy M.E. Coccia, F. Cammilli, L. Ginocchini, F. Borruto* and F. Rizzello Dept Gynaecology Perinatology and Human

More information

Does previous response to clomifene citrate influence the selection of gonadotropin dosage given in subsequent superovulation treatment cycles?

Does previous response to clomifene citrate influence the selection of gonadotropin dosage given in subsequent superovulation treatment cycles? J Assist Reprod Genet (26) 23:427 431 DOI 1.17/s1815-6-965-x ASSISTED REPRODUCTION Does previous response to clomifene citrate influence the selection of gonadotropin dosage given in subsequent superovulation

More information

In Vitro Fertilization in Clomiphene-Resistant Women with Polycystic Ovary Syndrome

In Vitro Fertilization in Clomiphene-Resistant Women with Polycystic Ovary Syndrome Original Article Effect of Laparoscopic Ovarian Drilling on Outcomes of In Vitro Fertilization in Clomiphene-Resistant Women with Polycystic Ovary Syndrome Maryam Eftekhar, M.D. 1, Razieh Deghani Firoozabadi,

More information

Three-dimensional ultrasonographic ovarian measurements and in vitro fertilization outcome are related to age

Three-dimensional ultrasonographic ovarian measurements and in vitro fertilization outcome are related to age FERTILITY AND STERILITY VOL. 79, NO. 1, JANUARY 2003 Copyright 2003 American Society for Reproductive Medicine Published by Elsevier Science Inc. Printed on acid-free paper in U.S.A. Three-dimensional

More information

The effect of adding oral oestradiol to progesterone as luteal phase support in ART cycles a randomized controlled study

The effect of adding oral oestradiol to progesterone as luteal phase support in ART cycles a randomized controlled study Clinical research The effect of adding oral oestradiol to progesterone as luteal phase support in ART cycles a randomized controlled study Ashraf Moini 1,2, Shahrzad Zadeh Modarress 3, Elham Amirchaghmaghi

More information

Transvaginal three-dimensional ultrasound: reproducibility of ovarian and endometrial volume measurements

Transvaginal three-dimensional ultrasound: reproducibility of ovarian and endometrial volume measurements FERTLTY AND STERL'fi' Copyright 1996 American Society for Reproductive Medicine Vol. 66, No.5, November 1996 Printed on acid free paper in U. S. A. Transvaginal three-dimensional ultrasound: reproducibility

More information

Three-dimensional ultrasound features of the polycystic ovary and the effect of different phenotypic expressions on these parameters

Three-dimensional ultrasound features of the polycystic ovary and the effect of different phenotypic expressions on these parameters Human Reproduction Vol.22, No.12 pp. 3116 3123, 2007 Advance Access publication on October 18, 2007 doi:10.1093/humrep/dem218 Three-dimensional ultrasound features of the polycystic ovary and the effect

More information

Clinical consequences of ovarian stimulation in assisted conception and in PCOS Al-Inany, H.G.

Clinical consequences of ovarian stimulation in assisted conception and in PCOS Al-Inany, H.G. UvA-DARE (Digital Academic Repository) Clinical consequences of ovarian stimulation in assisted conception and in PCOS Al-Inany, H.G. Link to publication Citation for published version (APA): Al-Inany,

More information

Premature progesterone elevation impairs implantation and live birth rates in GnRH-agonist IVF/ICSI cycles

Premature progesterone elevation impairs implantation and live birth rates in GnRH-agonist IVF/ICSI cycles Arch Gynecol Obstet (2010) 281:747 752 DOI 10.1007/s00404-009-1248-0 REPRODUCTIVE MEDICINE Premature progesterone elevation impairs implantation and live birth rates in GnRH-agonist IVF/ICSI cycles Esra

More information

Prognostic factors of ovarian response and IVF outcome in patients with deep infiltrating endometriosis Claire GAUCHE-CAZALIS, Chadi YAZBECK

Prognostic factors of ovarian response and IVF outcome in patients with deep infiltrating endometriosis Claire GAUCHE-CAZALIS, Chadi YAZBECK Prognostic factors of ovarian response and IVF outcome in patients with deep infiltrating endometriosis Claire GAUCHE-CAZALIS, Chadi YAZBECK Obstetrics Gynecology and Reproductive Medicine Department Bichat

More information

Does triggering ovulation by 5000 IU of uhcg affect ICSI outcome? *

Does triggering ovulation by 5000 IU of uhcg affect ICSI outcome? * Middle East Fertility Society Journal Vol. 11, No. 2, 2006 Copyright Middle East Fertility Society Does triggering ovulation by 5000 IU of uhcg affect ICSI outcome? * Amany A.M. Shaltout, M.D. Mohamed

More information

IVF (,, ) : (HP-hMG) - (IVF- ET) : GnRH, HP-hMG (HP-hMG )57, (rfsh )140, (Gn)

IVF (,, ) : (HP-hMG) - (IVF- ET) : GnRH, HP-hMG (HP-hMG )57, (rfsh )140, (Gn) 34 11 Vol.34 No.11 2014 11 Nov. 2014 Reproduction & Contraception doi: 10.7669/j.issn.0253-3X.2014.11.0892 E-mail: randc_journal@163.com IVF ( 710003) : (H-hMG) - (IVF- ET) : GnRH H-hMG (H-hMG ) (rfsh

More information

I. ART PROCEDURES. A. In Vitro Fertilization (IVF)

I. ART PROCEDURES. A. In Vitro Fertilization (IVF) DFW Fertility Associates ASSISTED REPRODUCTIVE TECHNOLOGY (ART) Welcome to DFW Fertility Associates/ Presbyterian-Harris Methodist Hospital ARTS program. This document provides an overview of treatment

More information

Comparison of anti-mullerian hormone and antral follicle count for assessment of ovarian reserve

Comparison of anti-mullerian hormone and antral follicle count for assessment of ovarian reserve Original Article Comparison of anti-mullerian hormone and antral follicle count for assessment of ovarian reserve Sonal Panchal, Chaitanya Nagori Dr. Nagori s Institute for Infertility and IVF, Ellisbridge,

More information

Ovarian response in three consecutive in vitro fertilization cycles

Ovarian response in three consecutive in vitro fertilization cycles FERTILITY AND STERILITY VOL. 77, NO. 4, APRIL 2002 Copyright 2002 American Society for Reproductive Medicine Published by Elsevier Science Inc. Printed on acid-free paper in U.S.A. Ovarian response in

More information

LOW RESPONDERS. Poor Ovarian Response, Por

LOW RESPONDERS. Poor Ovarian Response, Por LOW RESPONDERS Poor Ovarian Response, Por Patients with a low number of retrieved oocytes despite adequate ovarian stimulation during fertility treatment. Diagnosis Female About Low responders In patients

More information

Three-Dimensional Ultrasonographic Bladder Volume Measurement

Three-Dimensional Ultrasonographic Bladder Volume Measurement Article Three-Dimensional Ultrasonographic Bladder Volume Measurement Reliability of the Virtual Organ Computer-Aided Analysis Technique Using Different Rotation Steps Chitkasaem Suwanrath, MD, MMedSci,

More information

Fixed Schedule for in vitro Fertilization and Embryo Transfer: Comparison of Outcome between the Short and the Long Protocol

Fixed Schedule for in vitro Fertilization and Embryo Transfer: Comparison of Outcome between the Short and the Long Protocol Yamanashi Med. J. 14(3), 77 ~ 82, 1999 Original Article Fixed Schedule for in vitro Fertilization and Embryo Transfer: Comparison of Outcome between the Short and the Long Protocol Tsuyoshi KASAI and Kazuhiko

More information

Comparison of changes in uterine contraction frequency after ovulation in the menstrual cycle and in in vitro fertilization cycles

Comparison of changes in uterine contraction frequency after ovulation in the menstrual cycle and in in vitro fertilization cycles FERTILITY AND STERILITY VOL. 79, NO. 5, MAY 2003 Copyright 2003 American Society for Reproductive Medicine Published by Elsevier Inc. Printed on acid-free paper in U.S.A. Comparison of changes in uterine

More information

Department of Obstetrics and Gynecology, The University of Texas Health Science Center at San Antonio, San Antonio, Texas

Department of Obstetrics and Gynecology, The University of Texas Health Science Center at San Antonio, San Antonio, Texas FERTILITY AND STERILITY Copyright 1991 The American Fertility Society Vol. 56, No. 2, August 1991 Printed on ocid-free paper in U.S.A. Follicular size at the time of human chorionic gonadotropin administration

More information

Hana Park, Chung-Hoon Kim, Eun-Young Kim, Jei-Won Moon, Sung-Hoon Kim, Hee-Dong Chae, Byung-Moon Kang

Hana Park, Chung-Hoon Kim, Eun-Young Kim, Jei-Won Moon, Sung-Hoon Kim, Hee-Dong Chae, Byung-Moon Kang Original Article Obstet Gynecol Sci 2015;58(6):481-486 http://dx.doi.org/10.5468/ogs.2015.58.6.481 pissn 2287-8572 eissn 2287-8580 Effect of second-line surgery on in vitro fertilization outcome in infertile

More information

Original Article. KEY WORDS: Doppler, endometrial thickness, in-vitro fertilization

Original Article. KEY WORDS: Doppler, endometrial thickness, in-vitro fertilization Original Article Predictive value of endometrial thickness, pattern and sub-endometrial blood flows on the day of hcg by 2D Doppler in in-vitro fertilization cycles: A prospective clinical study from a

More information

Recent Developments in Infertility Treatment

Recent Developments in Infertility Treatment Recent Developments in Infertility Treatment John T. Queenan Jr., MD Professor, Dept. Of Ob/Gyn University of Rochester Medical Center Rochester, NY Disclosures I don t have financial interest or other

More information

The association between anti-müllerian hormone and IVF pregnancy outcomes is influenced by age

The association between anti-müllerian hormone and IVF pregnancy outcomes is influenced by age Reproductive BioMedicine Online (2010) 21, 757 761 www.sciencedirect.com www.rbmonline.com ARTICLE The association between anti-müllerian hormone and IVF pregnancy outcomes is influenced by age Jeff G

More information

Menstruation-free interval and ongoing pregnancy in IVF using GnRH antagonists

Menstruation-free interval and ongoing pregnancy in IVF using GnRH antagonists Human Reproduction Vol.21, No.4 pp. 1012 1017, 2006 Advance Access publication December 8, 2005. doi:10.1093/humrep/dei415 Menstruation-free interval and ongoing pregnancy in IVF using GnRH antagonists

More information

Comparison of serum and follicular fluid hormone levels with recombinant and urinary human chorionic gonadotropin during in vitro fertilization

Comparison of serum and follicular fluid hormone levels with recombinant and urinary human chorionic gonadotropin during in vitro fertilization Comparison of serum and follicular fluid hormone levels with recombinant and urinary human chorionic gonadotropin during in vitro fertilization Peter Kovacs, M.D., a Timea Kovats, M.D., a Artur Bernard,

More information

Duration of progesterone-in-oil support after in vitro fertilization and embryo transfer: a randomized, controlled trial

Duration of progesterone-in-oil support after in vitro fertilization and embryo transfer: a randomized, controlled trial Duration of progesterone-in-oil support after in vitro fertilization and embryo transfer: a randomized, controlled trial Christine S. Goudge, M.D., Theodore C. Nagel, M.D., and Mark A. Damario, M.D. Division

More information

Luteal phase rescue after GnRHa triggering Progesterone and Estradiol

Luteal phase rescue after GnRHa triggering Progesterone and Estradiol Luteal phase rescue after GnRHa triggering Progesterone and Estradiol L. Engmann University of Connecticut Disclaimer Fertility Speaker Bureau Merck Pharmaceuticals Introduction GnRH agonist is effective

More information

A critical review of bi-dimensional and threedimensional ultrasound techniques to monitor follicle growth: do they help improving IVF outcome?

A critical review of bi-dimensional and threedimensional ultrasound techniques to monitor follicle growth: do they help improving IVF outcome? Revelli et al. Reproductive Biology and Endocrinology 2014, 12:107 REVIEW Open Access A critical review of bi-dimensional and threedimensional ultrasound techniques to monitor follicle growth: do they

More information

lbt lab tests t Conrolled Ovarian Hyperstimulation Dr Soheila Ansaripour

lbt lab tests t Conrolled Ovarian Hyperstimulation Dr Soheila Ansaripour lbt lab tests t and Conrolled Ovarian Hyperstimulation Dr Soheila Ansaripour Research Instituteof Avicenna 4/23/2012 Why good prediction of poor response good prediction i of OHSS application appropriate

More information

A comparative study between agonist and antagonist protocol for ovarian stimulation in art cycles at a rural set up in South Gujarat

A comparative study between agonist and antagonist protocol for ovarian stimulation in art cycles at a rural set up in South Gujarat International Journal of Reproduction, Contraception, Obstetrics and Gynecology Nadkarni PK et al. Int J Reprod Contracept Obstet Gynecol. 2015 Jun;4(3):617-621 www.ijrcog.org pissn 2320-1770 eissn 2320-1789

More information

Hormonal Assays. MATERIALS AND METHODS Experimental Design. Treatment Protocol. Data Acquisition. Data Analysis. Statistical Analysis

Hormonal Assays. MATERIALS AND METHODS Experimental Design. Treatment Protocol. Data Acquisition. Data Analysis. Statistical Analysis The cohort of antral follicles measuring 2 6 mm reflects the quantitative status of ovarian reserve as assessed by serum levels of anti-m ullerian hormone and response to controlled ovarian stimulation

More information

LUTEAL PHASE SUPPORT. Doç. Dr. Nafiye Yılmaz. Zekai Tahir Burak Kadın Sağlığı Eğitim Araştırma Hastanesi

LUTEAL PHASE SUPPORT. Doç. Dr. Nafiye Yılmaz. Zekai Tahir Burak Kadın Sağlığı Eğitim Araştırma Hastanesi LUTEAL PHASE SUPPORT Doç. Dr. Nafiye Yılmaz Zekai Tahir Burak Kadın Sağlığı Eğitim Araştırma Hastanesi TAJEV, 2014 1 ART & success *Live birth rate 2 Optimal luteal phase Etiology of luteal phase deficiency

More information

OVULATION INDUCTION. Hsiang, Kaohsiung, Taiwan (FAX: ; adm.cgmh.org.tw).

OVULATION INDUCTION. Hsiang, Kaohsiung, Taiwan (FAX: ;   adm.cgmh.org.tw). OVULATION INDUCTION Significantly superior response in the right ovary compared with the left ovary after stimulation with follicle-stimulating hormone in a pituitary down-regulation regimen Kuo-Chung

More information

Objective: To study the role of sildenafil on the echogenic pattern of endometrium in infertile patients with bad endometrium.

Objective: To study the role of sildenafil on the echogenic pattern of endometrium in infertile patients with bad endometrium. The effect of Sildenafil on endometrial characters in patients with infertility Ali F. Al-Assadi, F.I.C.O.G.,C.A.B.O.G.1. Sajeda A. Al-Rubaye, F.I.C.O.G.1 Zainab Laaiby, M.B.Ch.B.2 (1- Assist. Prof./Basra

More information

Pituitary down-regulation in IVF/ICSI: consequences for treatment regimens Mochtar, M.H.

Pituitary down-regulation in IVF/ICSI: consequences for treatment regimens Mochtar, M.H. UvA-DARE (Digital Academic Repository) Pituitary down-regulation in IVF/ICSI: consequences for treatment regimens Mochtar, M.H. Link to publication Citation for published version (APA): Mochtar, M. H.

More information

Antral follicle count as a predictor of ovarian response

Antral follicle count as a predictor of ovarian response Original article Antral follicle count as a predictor of ovarian response N. Lonegro a, N. Napoli a,*, R. Pesce b and C. Chacón a a Imaging Department, Hospital Italiano de Buenos Aires, Ciudad Autónoma

More information

Vaginal micronized progesterone versus intramuscular progesterone for luteal support in women undergoing in vitro fertilization embryo transfer

Vaginal micronized progesterone versus intramuscular progesterone for luteal support in women undergoing in vitro fertilization embryo transfer Vaginal micronized progesterone versus intramuscular progesterone for luteal support in women undergoing in vitro fertilization embryo transfer Mohamed F. Mitwally, M.D., H.C.L.D., a Michael P. Diamond,

More information

The outcome of in-vitro fertilization treatment in women with sonographic evidence of polycystic ovarian morphology

The outcome of in-vitro fertilization treatment in women with sonographic evidence of polycystic ovarian morphology Human Reproduction vol.14 no.1 pp.167 171, 1999 The outcome of in-vitro fertilization treatment in women with sonographic evidence of polycystic ovarian morphology Lawrence Engmann 1,2,5, Noreen Maconochie

More information

Article Depot GnRH agonist versus the single dose GnRH antagonist regimen (cetrorelix, 3 mg) in patients undergoing assisted reproduction treatment

Article Depot GnRH agonist versus the single dose GnRH antagonist regimen (cetrorelix, 3 mg) in patients undergoing assisted reproduction treatment RBMOnline - Vol 7. No 2. 185 189 Reproductive BioMedicine Online; www.rbmonline.com/article/900 on web 18 June 2003 Article Depot GnRH agonist versus the single dose GnRH antagonist regimen (cetrorelix,

More information

Original Article. Fauzia HaqNawaz 1*, Saadia Virk 2, Tasleem Qadir 3, Saadia Imam 3, Javed Rizvi 2

Original Article. Fauzia HaqNawaz 1*, Saadia Virk 2, Tasleem Qadir 3, Saadia Imam 3, Javed Rizvi 2 Original Article Comparison of Letrozole and Clomiphene Citrate Efficacy along with Gonadotrophins in Controlled Ovarian Hyperstimulation for Intrauterine Insemination Cycles Fauzia HaqNawaz 1*, Saadia

More information

A Case of Pregnancy Using Recombinant Follicle Stimulating Hormone and Gonadotropin Releasing Hormone Antagonist

A Case of Pregnancy Using Recombinant Follicle Stimulating Hormone and Gonadotropin Releasing Hormone Antagonist 1 *, ** * * * ** A Case of Pregnancy Using Recombinant Follicle Stimulating Hormone and Gonadotropin Releasing Hormone Antagonist Yoon Sung Nam, Nam Keun Kim*, Eun Kyung Kim**, Hyung Min Chung** and Kwang

More information

Antral follicle count in clinical practice: analyzing clinical relevance

Antral follicle count in clinical practice: analyzing clinical relevance CONTROVERSY I Antral follicle count in clinical practice: analyzing clinical relevance Albert Hsu, M.D., Margaret Arny, Ph.D., Alexander B. Knee, M.S., Carrie Bell, M.D., Elizabeth Cook, Ph.D., Amy L.

More information

Effect of ovarian stimulation on oocyte quality and embryonic aneuploidy: a prospective, randomised controlled trial

Effect of ovarian stimulation on oocyte quality and embryonic aneuploidy: a prospective, randomised controlled trial FULL PROJECT TITLE: Effect of ovarian stimulation on oocyte quality and embryonic aneuploidy: a prospective, randomised controlled trial (STimulation Resulting in Embryonic Aneuploidy using Menopur (STREAM)

More information

Minimal stimulation using recombinant follicle-stimulating hormone and a gonadotropin-releasing hormone antagonist in women of advanced age

Minimal stimulation using recombinant follicle-stimulating hormone and a gonadotropin-releasing hormone antagonist in women of advanced age FERTILITY AND STERILITY VOL. 81, NO. 4, APRIL 2004 Copyright 2004 American Society for Reproductive Medicine Published by Elsevier Inc. Printed on acid-free paper in U.S.A. Minimal stimulation using recombinant

More information

Ovarian stimulation to cryopreserve fertilized oocytes in cancer patients can be started in the luteal phase

Ovarian stimulation to cryopreserve fertilized oocytes in cancer patients can be started in the luteal phase Ovarian stimulation to cryopreserve fertilized oocytes in cancer patients can be started in the luteal phase Michael von Wolff, M.D., a Christian J. Thaler, M.D., b Torsten Frambach, M.D., c Cosima Zeeb,

More information

Evaluation of ovarian response prediction according to age and serum AMH levels in IVF cycles: a retrospective analysis

Evaluation of ovarian response prediction according to age and serum AMH levels in IVF cycles: a retrospective analysis International Journal of Reproduction, Contraception, Obstetrics and Gynecology Pillai SM et al. Int J Reprod Contracept Obstet Gynecol. 2017 Aug;6(8):3306-3310 www.ijrcog.org DOI: http://dx.doi.org/10.18203/2320-1770.ijrcog20173190

More information

The Egyptian Journal of Hospital Medicine (January 2019) Vol. 74 (4), Page

The Egyptian Journal of Hospital Medicine (January 2019) Vol. 74 (4), Page The Egyptian Journal of Hospital Medicine (January 2019) Vol. 74 (4), Page 858-866 Comparative study between fixed and flexible GnRH antagonist protocol versus GnRH agonist long protocol in polycystic

More information

Estradiol Level on Day 2 and Day of Trigger: A Potential Predictor of the IVF-ET Success

Estradiol Level on Day 2 and Day of Trigger: A Potential Predictor of the IVF-ET Success DOI 10.1007/s13224-014-0515-6 ORIGINAL ARTICLE Estradiol Level on Day 2 and Day of Trigger: A Potential Predictor of the IVF-ET Success Prasad Sudha Kumar Yogesh Singhal Megha Sharma Shashi Received: 27

More information

Follicular fluid steroid hormone levels are associated with fertilization outcome after intracytoplasmic sperm injection

Follicular fluid steroid hormone levels are associated with fertilization outcome after intracytoplasmic sperm injection Follicular fluid steroid hormone levels are associated with fertilization outcome after intracytoplasmic sperm injection Julie D. Lamb, M.D., a A. Musa Zamah, M.D., Ph.D., a Shehua Shen, M.D., a Charles

More information

Comparison of NuvaRing and Desogen in IVF cycles with ganirelix acetate

Comparison of NuvaRing and Desogen in IVF cycles with ganirelix acetate J Obstet Gynecol India Vol. 57, No. 3 : May/June 2007 Pg 234-239 ORIGINAL ARTICLE The Journal of Obstetrics and Gynecology of India Comparison of NuvaRing and Desogen in IVF cycles with ganirelix acetate

More information

Clinical Study Clinical Effects of a Natural Extract of Urinary Human Menopausal Gonadotrophin in Normogonadotropic Infertile Patients

Clinical Study Clinical Effects of a Natural Extract of Urinary Human Menopausal Gonadotrophin in Normogonadotropic Infertile Patients International Reproductive Medicine Volume 2013, Article ID 135258, 4 pages http://dx.doi.org/10.1155/2013/135258 Clinical Study Clinical Effects of a Natural Extract of Urinary Human Menopausal Gonadotrophin

More information

Orgalutran 0.25 mg/0.5 ml solution for injection 2. QUALITATIVE AND QUANTITATIVE COMPOSITION

Orgalutran 0.25 mg/0.5 ml solution for injection 2. QUALITATIVE AND QUANTITATIVE COMPOSITION 1 1. NAME OF THE MEDICINAL PRODUCT 0.25 mg/0.5 ml solution for injection 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each pre-filled syringe contains 0.25 mg of ganirelix (INN) in 0.5 mg aqueous solution.

More information

COMPARING AMH, AFC AND FSH FOR PREDICTING HIGH OVARIAN RESPONSE IN WOMEN UNDERGOING ANTAGONIST PROTOCOL

COMPARING AMH, AFC AND FSH FOR PREDICTING HIGH OVARIAN RESPONSE IN WOMEN UNDERGOING ANTAGONIST PROTOCOL COMPARING AMH, AFC AND FSH FOR PREDICTING HIGH OVARIAN RESPONSE IN WOMEN UNDERGOING ANTAGONIST PROTOCOL Nguyen Xuan Hoi1, Nguyen Manh Ha2 1 National Obstetrics and Gynecology Hospital, 2Hanoi Medical Unviversity

More information

A Tale of Three Hormones: hcg, Progesterone and AMH

A Tale of Three Hormones: hcg, Progesterone and AMH A Tale of Three Hormones: hcg, Progesterone and AMH Download the Ferring AR ipad/iphone app from the Apple Store: http://bit.ly/1okk74m Human Ovarian Steroidogenesis and Gonadotrophin Stimulation Johan

More information

(BMI)=18.0~24.9 kg/m 2 ;

(BMI)=18.0~24.9 kg/m 2 ; 33 10 Vol.33 No.10 2013 10 Oct. 2013 Reproduction & Contraception doi: 10.7669/j.issn.0253-357X.2013.10.0672 E-mail: randc_journal@163.com - ( 400013) : () GnRH-a - () : IVF- ET 233 A (I~II 102 ) B (III~IV

More information

Drug Therapy Guidelines

Drug Therapy Guidelines Drug Therapy Guidelines Applicable Injectable Fertility Medications: Bravelle, Cetrotide, Follistim AQ, Ganirelix, Gonal-F, human chorionic gonadotropin, leuprolide, Menopur, Novarel, Ovidrel, Pregnyl,

More information

Cigna Drug and Biologic Coverage Policy

Cigna Drug and Biologic Coverage Policy Cigna Drug and Biologic Coverage Policy Subject Infertility Injectables Table of Contents Coverage Policy... 1 General Background...16 Coding/Billing Information...20 References...20 Effective Date...

More information

Three-dimensional Ultrasound in Evaluation of the Ovary

Three-dimensional Ultrasound in Evaluation of the Ovary Journal of Medical Ultrasound (2012) 20, 136e141 Available online at www.sciencedirect.com journal homepage: www.jmu-online.com REVIEW ARTICLE Three-dimensional Ultrasound in Evaluation of the Ovary Meng-Hsing

More information

Agonist versus antagonist in ICSI cycles: a randomized trial and cost effectiveness analysis Badrawi A, Zaki S, Al-Inany H, Ramzy A M, Hussein M

Agonist versus antagonist in ICSI cycles: a randomized trial and cost effectiveness analysis Badrawi A, Zaki S, Al-Inany H, Ramzy A M, Hussein M Agonist versus antagonist in ICSI cycles: a randomized trial and cost effectiveness analysis Badrawi A, Zaki S, Al-Inany H, Ramzy A M, Hussein M Record Status This is a critical abstract of an economic

More information

Drug Therapy Guidelines

Drug Therapy Guidelines Drug Therapy Guidelines Applicable Medical Benefit Effective: 8/15/18 Pharmacy- Formulary 1 x Next Review: 6/18 Pharmacy- Formulary 2 x Date of Origin: 7/00 Injectable Fertility Medications: Bravelle,

More information

Prognosticating ovarian reserve by the new ovarian response prediction index

Prognosticating ovarian reserve by the new ovarian response prediction index International Journal of Reproduction, Contraception, Obstetrics and Gynecology Tak A et al. Int J Reprod Contracept Obstet Gynecol. 2018 Mar;7(3):1196-1200 www.ijrcog.org DOI: http://dx.doi.org/10.18203/2320-1770.ijrcog20180917

More information

Serum Estradiol Level as a Predictor of Ovarian Response and Pregnancy Outcome During Controlled Ovarian Hyperstimulation in Women from Gaza Strip

Serum Estradiol Level as a Predictor of Ovarian Response and Pregnancy Outcome During Controlled Ovarian Hyperstimulation in Women from Gaza Strip J MEDICINE 2013; 14 : 52-56 Serum Estradiol Level as a Predictor of Ovarian Response and Pregnancy Outcome During Controlled Ovarian Hyperstimulation in Women from Gaza Strip MAGED M. YASSIN, 1 MOHAMMED

More information

Milan Reljič, Ph.D., Veljko Vlaisavljević, Ph.D., Vida Gavrić, M.Sc., Borut Kovačič, Ph.D.,

Milan Reljič, Ph.D., Veljko Vlaisavljević, Ph.D., Vida Gavrić, M.Sc., Borut Kovačič, Ph.D., FERTILITY AND STERILITY VOL. 75, NO. 3, MARCH 2001 Copyright 2001 American Society for Reproductive Medicine Published by Elsevier Science Inc. Printed on acid-free paper in U.S.A. Value of the serum estradiol

More information

Natural Cycle & Mild stimulation IVF/ICSI in women with Poor Ovarian Response (POR)

Natural Cycle & Mild stimulation IVF/ICSI in women with Poor Ovarian Response (POR) Natural Cycle & Mild stimulation IVF/ICSI in women with Poor Ovarian Response (POR) Geeta Nargund Head of Reproductive Medicine St George s Hospital London ISMAAR Terminology Human Reprod Nargund et al

More information

Follicle-stimulating hormone/luteinizing hormone ratio as an independent predictor of response to controlled ovarian stimulation

Follicle-stimulating hormone/luteinizing hormone ratio as an independent predictor of response to controlled ovarian stimulation Follicle-stimulating hormone/luteinizing hormone ratio as an independent predictor of response to controlled ovarian stimulation Aim: To determine whether a follicle-stimulating hormone (FSH)/luteinizing

More information

in vitro fertilization

in vitro fertilization FERTILITY AND STERILITY VOL 69, NO. 6, JUNE 1998 Copyright (#1998 American Society for Reproductive Medicine Published by Elsevier Science Inc. Printed on acid-free paper in U.S.A. Elevated levels of basal

More information

In vitro fertilization outcome in frozen versus fresh embryo transfer in women with elevated progesterone level on the day of HCG injection: An RCT

In vitro fertilization outcome in frozen versus fresh embryo transfer in women with elevated progesterone level on the day of HCG injection: An RCT Int J Reprod BioMed Vol. 15. No. 12. pp: 757-762, December 2017 Original article In vitro fertilization outcome in frozen versus fresh embryo transfer in women with elevated progesterone level on the day

More information

Medicine. Wei Yang, MMed, Tao Zhang, MMed, Zhou Li, PhD, Xinling Ren, PhD, Bo Huang, PhD, Guijin Zhu, MMed, Lei Jin, PhD. Observational Study

Medicine. Wei Yang, MMed, Tao Zhang, MMed, Zhou Li, PhD, Xinling Ren, PhD, Bo Huang, PhD, Guijin Zhu, MMed, Lei Jin, PhD. Observational Study Observational Study Medicine Combined analysis of endometrial thickness and pattern in predicting clinical outcomes of frozen embryo transfer cycles with morphological good-quality blastocyst A retrospective

More information

Utility of in vitro fertilization at diagnostic laparoscopy*

Utility of in vitro fertilization at diagnostic laparoscopy* FERTILITY AND STERILITY Copyright" 1994 The American Fertility Society Printed on acid-free paper in U. S. A. Utility of in vitro fertilization at diagnostic laparoscopy* Paul R. Gindoff, M.D.t Jerry L.

More information

hmg-ibsa Final Report, 06 June 2014

hmg-ibsa Final Report, 06 June 2014 1 TITLE PAGE Safety and efficacy study comparing a new hmg formulation (hmg-ibsa) to a reference product (Menopur ) in patients undergoing ovarian stimulation for in vitro fertilisation (IVF). Study No:

More information

Nitasha Garg 1 Harkiran Kaur Khaira. About the Author

Nitasha Garg 1 Harkiran Kaur Khaira. About the Author https://doi.org/10.1007/s13224-017-1082-4 ORIGINAL ARTICLE A Comparative Study on Quantitative Assessment of Blood Flow and Vascularization in Polycystic Ovary Syndrome Patients and Normal Women Using

More information

Timur Giirgan, M.D.* Bulent Urman, M.D. Hakan Yarali, M.D. Hakan E. Duran, M.D.

Timur Giirgan, M.D.* Bulent Urman, M.D. Hakan Yarali, M.D. Hakan E. Duran, M.D. FERTILITY AND STEFULI~ Vol. 68, No. 3, September 1997 Copyright 1997 American Society for Reproductive Medicine Printed on acid-free paper in U. S. A. Published by Elsevier Science Inc. Follicle-stimulating

More information

S. DEB*, B. K. CAMPBELL, J. S. CLEWES, C. PINCOTT-ALLEN and N. J. RAINE-FENNING

S. DEB*, B. K. CAMPBELL, J. S. CLEWES, C. PINCOTT-ALLEN and N. J. RAINE-FENNING Ultrasound Obstet Gynecol 2013; 41: 21 222 Published online in Wiley Online Library (wileyonlinelibrary.com). DOI:.02/uog.1122 Intracycle variation in number of antral follicles stratified by size and

More information

In Vitro Fertilization and Embryo Transfer

In Vitro Fertilization and Embryo Transfer Acta Medica et Biologica Vol. 41, No.4, 171-176, 1993 The Influence of Low Ovarian Response on the Results of In Vitro Fertilization and Embryo Transfer Hirofumi HIRASAWA Department of Obstetrics and Gynecology,

More information

2017 United HealthCare Services, Inc.

2017 United HealthCare Services, Inc. UnitedHealthcare Pharmacy Clinical Pharmacy Programs Program Number 2017 P 1143-4 Program Prior Authorization/Notification Medication Menopur (menotropins) * P&T Approval Date 8/2014, 5/2015, 5/2016, 5/2017

More information

Understanding Infertility, Evaluations, and Treatment Options

Understanding Infertility, Evaluations, and Treatment Options Understanding Infertility, Evaluations, and Treatment Options Arlene J. Morales, M.D., F.A.C.O.G. Fertility Specialists Medical Group, Inc. What We Will Cover Introduction What is infertility? Briefly

More information

Serum progesterone levels on the day of hcg trigger and ICSI outcome: a retrospective observational cohort study

Serum progesterone levels on the day of hcg trigger and ICSI outcome: a retrospective observational cohort study International Journal of Reproduction, Contraception, Obstetrics and Gynecology Amin KV et al. Int J Reprod Contracept Obstet Gynecol. 2018 Aug;7(8):3194-3198 www.ijrcog.org DOI: http://dx.doi.org/10.18203/2320-1770.ijrcog20183316

More information

Milder is better? Advantages and disadvantages of "mild" ovarian stimulation for human in vitro fertilization

Milder is better? Advantages and disadvantages of mild ovarian stimulation for human in vitro fertilization Milder is better? Advantages and disadvantages of "mild" ovarian stimulation for human in vitro fertilization Revelli et al. Reproductive Biology and Endocrinology 2011, 9:25 Presenter: R2 孫怡虹 Background

More information

Is it the seed or the soil? Arthur Leader, MD, FRCSC

Is it the seed or the soil? Arthur Leader, MD, FRCSC The Physiological Limits of Ovarian Stimulation Is it the seed or the soil? Arthur Leader, MD, FRCSC Objectives 1. To consider how ovarian stimulation protocols work in IVF 2. To review the key events

More information

Neil Goodman, MD, FACE

Neil Goodman, MD, FACE Initial Workup of Infertile Couple: Female Neil Goodman, MD, FACE Professor of Medicine Voluntary Faculty University of Miami Miller School of Medicine Scope of Infertility in the United States Affects

More information

Original Article Impact of estrogen-to-oocyte ratio on live birth rate in women undergoing in vitro fertilization and embryo transfer

Original Article Impact of estrogen-to-oocyte ratio on live birth rate in women undergoing in vitro fertilization and embryo transfer Int J Clin Exp Med 2015;8(7):11327-11331 www.ijcem.com /ISSN:1940-5901/IJCEM0008838 Original Article Impact of estrogen-to-oocyte ratio on live birth rate in women undergoing in vitro fertilization and

More information

Laboratoires Genevirer Menotrophin IU 1.8.2

Laboratoires Genevirer Menotrophin IU 1.8.2 Important missing information VI.2 VI.2.1 Elements for a Public Summary Overview of disease epidemiology Infertility is when a woman cannot get pregnant (conceive) despite having regular unprotected sexual

More information